Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles Jan 13, 2026 01:49PM
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement Jan 8, 2026 04:38PM
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement Dec 30, 2025 03:58PM
KeyBanc on Lifecore Biomedical (LFCR): 'Recent Announcements Indicate Momentum & Strategic Value Is Building' Dec 29, 2025 07:29AM
Lifecore Biomedical (LFCR) Tops Q3 EPS by 3c ; Offers Guidance Nov 6, 2025 04:21PM


Oct 29, 2025 07:02AM Lifecore Biomedical wins commercial manufacturing deal with global pharma firm
Oct 28, 2025 07:02AM Lifecore and PolyPeptide partner for peptide manufacturing in US
Sep 23, 2025 06:13AM Lifecore Biomedical (LFCR) files for $150M share and warrant offering
Aug 7, 2025 04:18PM Lifecore Biomedical (LFCR) Misses Q2 EPS by 2c
Jun 17, 2025 07:03AM Lifecore Biomedical (LFCR) Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
Jun 12, 2025 07:01AM Lifecore Biomedical (LFCR) Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
May 27, 2025 07:03AM Lifecore Biomedical (LFCR) Appoints Mark DaFonseca as Chief Commercial Officer
May 21, 2025 06:31AM William Blair Starts Lifecore Biomedical (LFCR) at Outperform
Jan 3, 2025 07:10AM Stephens Reiterates Equal Weight Rating on Lifecore Biomedical (LFCR)
Jan 3, 2025 06:21AM Lifecore Biomedical (LFCR) Tops Q2 EPS by 2c
Dec 19, 2024 07:04AM Lifecore Biomedical (LFCR) Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Nov 26, 2024 04:12PM Lifecore Biomedical (LFCR) Amends and Extends Revolving Credit Facility with BMO
Nov 22, 2024 08:55AM Lifecore Biomedical (LFCR) PT Raised to $10 at Craig-Hallum
Nov 4, 2024 07:02AM Lifecore Biomedical (LFCR) Appoints Thomas Guldager as Vice President, Operations
Oct 10, 2024 04:39PM Lifecore Biomedical (LFCR) Files for 6.8M Share Offering by Selling Stockholders
Oct 7, 2024 09:19AM Lifecore Biomedical (LFCR) PT Raised to $6 at Stephens
Oct 4, 2024 01:16PM Stephens Reiterates Equal Weight Rating on Lifecore Biomedical (LFCR)
Oct 4, 2024 07:33AM Lifecore Biomedical (LFCR) Reports Q1 Loss of $0.53/sh
Oct 4, 2024 07:21AM Lifecore Biomedical (LFCR) Prices 5.93M Share Offering at $4.10/sh
Oct 1, 2024 07:06AM Lifecore Biomedical (LFCR) Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
Sep 12, 2024 07:02AM Lifecore Biomedical (LFCR) Regains Nasdaq Compliance
Aug 29, 2024 07:01AM Lifecore Biomedical (LFCR) Announces CFO Transition